Resultados de procura - Katharina Modelska

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials

    Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials por Katharina Modelska, Steven R. Cummings

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial

    Roxadustat versus placebo for patients with lower‐risk myelodysplastic syndrome: MATTERHORN phase 3, double‐blind, randomized controlled trial por Moshe Mittelman, David H. Henry, John A. Glaspy, Anıl Tombak, Rosemary Harrup, Inho Kim, Krzysztof Mądry, Barbara Grabowska, Tyson Lee, Katharina Modelska

    Publicado 2024
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer por Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal D. Shore, Ubirajara Ferreira, Petro Ivashchenko, Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N. Sternberg

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study

    Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study por David H. Henry, John A. Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E. Carraway, Charles W. Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert Leong, Kin‐Hung P. Yu

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of PROSPER by age and region

    A phase III, randomized, double-blind, placebo (PBO)-controlled study of enzalutamide (ENZA) in men with nonmetastatic (M0) castration-resistant prostate cancer (CRPC): Results of... por Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, Ugo De Giorgi, Eleni Efstathiou, Ubirajara Ferreira, Petro Ivashchenko, Katarzyna Madziarska, Mohammed Al-Adhami, Katharina Modelska, D. Phung, Joyce Steinberg, Cora N. Sternberg

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

    Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer por Cora N. Sternberg, Karim Fizazi, Fred Saad, Neal D. Shore, Ugo De Giorgi, David F. Penson, Ubirajara Ferreira, Eleni Efstathiou, Katarzyna Madziarska, Michael Paul Kolinsky, Daniel de Iracema Gomes Cubero, Bettina Noerby, Fabian Zohren, Xun Lin, Katharina Modelska, Jennifer Sugg, Joyce Steinberg, Maha Hussain

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: